Human Chorionic Gonadotropin Market Revenue 2024 to 2034
Human Chorionic Gonadotropin Market Revenue 2024 to 2034
According to forecasts, the global human chorionic gonadotropin market will grow from USD 808.17 million in 2024 to USD 1,522.76 million by 2034, with an expected CAGR of 6.54%. The rising prevalence of female infertility, increasing demand for in vitro fertilization, and growing research and development drive the market.
Report ID: 10205
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 808.17 Mn
Forecast Year,
USD USD 1,522.76 Mn
CAGR, 2025 -
6.54%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Human Chorionic Gonadotropin Market Size Analysis
Human Chorionic Gonadotropin Market Size By Product Type 2024 to 2034 (USD )
| Product Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Native Human Chorionic Gonadotropin | 565.72 | 600.99 | 638.47 | 678.27 | 720.54 | 765.45 | 813.14 | 863.80 | 917.61 | 974.77 | 1035.47 |
| Recombinant Human Chorionic Gonadotropin | 242.45 | 260.03 | 278.87 | 299.06 | 320.70 | 343.90 | 368.75 | 395.39 | 423.93 | 454.51 | 487.28 |
Human Chorionic Gonadotropin Market Size By Therapeutic Area 2024 to 2034 (USD )
| Therapeutic Area | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Female Infertility Treatment | 323.27 | 343.55 | 365.10 | 388.00 | 412.33 | 438.19 | 465.67 | 494.86 | 525.88 | 558.85 | 593.87 |
| Male Hypogonadism | 145.47 | 155.41 | 166.04 | 177.39 | 189.51 | 202.46 | 216.29 | 231.06 | 246.84 | 263.70 | 281.71 |
| Oligospermic Treatment | 96.98 | 103.75 | 111.00 | 118.75 | 127.03 | 135.89 | 145.37 | 155.51 | 166.35 | 177.95 | 190.34 |
| Cryptorchidism Treatment | 80.82 | 86.27 | 92.10 | 98.32 | 104.96 | 112.04 | 119.61 | 127.68 | 136.30 | 145.50 | 155.32 |
| Chronic Pain | 64.65 | 69.14 | 73.94 | 79.07 | 84.55 | 90.41 | 96.68 | 103.38 | 110.54 | 118.20 | 126.39 |
| Others | 96.98 | 102.89 | 109.16 | 115.81 | 122.87 | 130.35 | 138.28 | 146.70 | 155.62 | 165.08 | 175.12 |
Human Chorionic Gonadotropin Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 444.49 | 472.70 | 502.70 | 534.60 | 568.52 | 604.59 | 642.95 | 683.74 | 727.12 | 773.24 | 822.29 |
| Retail Pharmacies | 282.86 | 300.93 | 320.15 | 340.60 | 362.35 | 385.50 | 410.12 | 436.31 | 464.17 | 493.82 | 525.35 |
| Online Pharmacies | 80.82 | 87.39 | 94.49 | 102.13 | 110.37 | 119.25 | 128.83 | 139.14 | 150.25 | 162.22 | 175.12 |
Human Chorionic Gonadotropin Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 299.02 | 317.40 | 336.90 | 357.60 | 379.57 | 402.88 | 427.62 | 453.87 | 481.73 | 511.30 | 542.67 |
| Asia Pacific | 218.21 | 233.53 | 249.93 | 267.48 | 286.25 | 306.32 | 327.80 | 350.78 | 375.36 | 401.65 | 429.77 |
| Europe | 177.80 | 189.67 | 202.33 | 215.83 | 230.24 | 245.60 | 262.00 | 279.48 | 298.13 | 318.03 | 339.25 |
| Latin America | 64.65 | 68.38 | 72.32 | 76.49 | 80.89 | 85.54 | 90.45 | 95.64 | 101.13 | 106.92 | 113.04 |
| Middle East and Africa | 48.49 | 52.04 | 55.85 | 59.93 | 64.30 | 68.99 | 74.02 | 79.41 | 85.19 | 91.39 | 98.03 |
Human Chorionic Gonadotropin Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
